|
|
 |
 |
 |
| |
| |
|
With pricing
pressures worldwide a growing concern for the industry, strategic
pricing excellence has become a critical imperative for driving
pharmaceutical product returns. The concentration of strategic
pricing expertise and experience within Infusion thus represents
an important resource for pharmaceutical manufacturers.
While many approach pricing as a a technical discipline alone,
we consider it a vital, central high-impact component of the
strategic agenda and one brimming with untapped versatility,
creative strategic potential and ultimately value. |
| |
|
|
|
|
| |
|
Getting
pricing “right” has major implications for all
stakeholders. For manufacturers and their shareholders, it
can mean enhanced current returns and a more secure long-term
ability to re-invest in research. For patients, it can mean
better access to today’s valuable medications and more
in the future. And for payors, it can mean lower total healthcare
costs.
•
The Infusion Difference
• Strategic Pricing
& Public Policy Services
|
|
| The
Infusion Difference |
|
|
Infusion's
pricing practice is a distinct resource in several ways:
- True
Pricing Expertise
- Pharmaceutical pricing is a complex, highly interconnected
and ever-shifting arena that operates under intense public
and private market scrutiny. Missteps can be costly, irrevocable
and embarrassing. Infusion professionals bring genuine expertise
and long experience to this mission-critical area.
- Strategy-Driven
-
Pricing is a core strategic decision which impacts virtually
every other component of the development and commercialization
agenda. And we bring a strategist’s perspective to
the task. Unlike many pharmaceutical pricing “specialists”
our roots lie in strategy, not in technical sub-disciplines.
- Public
Policy Orientation
- Pharmaceutical pricing is inextricably linked to public
policy decisions worldwide that may have significant impact
on corporate returns. Infusion marries these disciplines
with its professionals bringing significant public policy
experience to issues of pricing.
|
| |
| Strategic
Pricing & Public Policy Services |
|
|
Strategic
pricing is not a single event but an integrated series of decisions
and actions taken over the course of a product’s life
that seeks to:
- Create,
optimize and document product value
- Participate
in the value created
- Maintain
and enhance value over the life of the product
Accordingly,
Infusion offers a range of services appropriate to products
regardless of their life cycle. These include:
- New
Product Pricing & Access - Our TOPS (Total
Optimized Pricing Strategy) service offers complete solutions
for optimizing and documenting emerging product value and
maximizing access. These include competitive positioning,
advanced pricing segmentation, price response analysis,
regional sequencing strategy, access planning and trials/documentation
to evidence value.
- Managed
Markets Strategy & Tactics - Comprehensive
approach to maximizing returns from public and private managed
market accounts. Services include managed markets strategy
at the product and corporate level and tactical execution
on an account by account basis. Focus encompasses managed
care, institutional accounts, alternate site providers,
Medicare and Medicaid.
- Medicare Prescription Drug Benefit Strategy - The Medicare Prescription Drug benefit introduces fresh strategic turbulence for pharma manufacturers. Millions of newly insured beneficiaries are sponsored, important new purchase entities created, and decision incentives altered. Infusion consultants are experts in the Medicare legislation and are supporting corporate and brand managements in developing uncertainty-tolerant response strategies for Parts B and D.
- Reimbursement
Strategy - Expert capabilities in reimbursement
planning and execution with a focus on compressing time
to effective reimbursement and optimizing peak reimbursement
levels. Focus includes private payors, Medicaid and Medicare
Parts A and B.
- Reimportation Policy - Infusion consultants in the US and Canada are uniquely positioned to assist manufacturers in addressing this politically-charged challenge. With a team that includes a former Canadian healthcare official, we can offer support for both short-term approaches and longer term strategic and policy initiatives.
- Public
Policy Management - This service includes
legislative and regulatory price defense, policy impact
assessment and strategy, pro-active policy management and
the development of patient access programs. The firm also
offers significant expertise in working productively with
advocacy groups toward common objectives.
|
|
|
|
|
|
|
|
